{
    "pmid": "41452552",
    "title": "Lipidomics analysis of ceramidase inhibition-induced intracellular lipid profile changes in lung cancer cells.",
    "abstract": "Lung cancer is among the most prevalent types of cancer globally and in TÃ¼rkiye. Basically, lung cancer is divided into 2 different types, of which non-small cell lung cancer (NSCLC) accounts for about 85% of cases. With the elucidation of the mechanism of NSCLC, there is an urgent need to identify effective non-toxic drugs and new target biomarkers. Therefore, an immediate need exists to clarify the mechanism of NSCLC and identify effective, nontoxic drugs and novel target biomarkers. In this study, we aimed to determine intracellular lipid level changes caused by N-Oleoylethanolamine (NOE) and N-Oleoylethanolamine Solid Lipid Nanoparticle (NOESLN) formulations in test cell lines determined by mass spectrometry LC-MS/MS lipidomic analysis. Lipid level changes induced by N-Oleoylethanolamine (NOE) and N-Oleoylethanolamine Solid Lipid Nanoparticle (NOESLN) formulations in test cell lines have been determined by mass spectrometry LC-MS/MS lipidomics analysis. The particle size of the nanoparticle formulation was found to be 100 times smaller compared to the NOE particle size. According to MTT results, IC",
    "disease": "lung cancer",
    "clean_text": "lipidomics analysis of ceramidase inhibition induced intracellular lipid profile changes in lung cancer cells lung cancer is among the most prevalent types of cancer globally and in t rkiye basically lung cancer is divided into different types of which non small cell lung cancer nsclc accounts for about of cases with the elucidation of the mechanism of nsclc there is an urgent need to identify effective non toxic drugs and new target biomarkers therefore an immediate need exists to clarify the mechanism of nsclc and identify effective nontoxic drugs and novel target biomarkers in this study we aimed to determine intracellular lipid level changes caused by n oleoylethanolamine noe and n oleoylethanolamine solid lipid nanoparticle noesln formulations in test cell lines determined by mass spectrometry lc ms ms lipidomic analysis lipid level changes induced by n oleoylethanolamine noe and n oleoylethanolamine solid lipid nanoparticle noesln formulations in test cell lines have been determined by mass spectrometry lc ms ms lipidomics analysis the particle size of the nanoparticle formulation was found to be times smaller compared to the noe particle size according to mtt results ic"
}